Axsome Therapeutics (AXSM) Current Leases (2022 - 2025)
Historic Current Leases for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to $2.5 million.
- Axsome Therapeutics' Current Leases rose 5347.26% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 5347.26%. This contributed to the annual value of $1.8 million for FY2024, which is 4483.03% up from last year.
- According to the latest figures from Q3 2025, Axsome Therapeutics' Current Leases is $2.5 million, which was up 5347.26% from $2.0 million recorded in Q2 2025.
- Axsome Therapeutics' Current Leases' 5-year high stood at $2.5 million during Q3 2025, with a 5-year trough of $108000.0 in Q1 2023.
- Its 4-year average for Current Leases is $1.1 million, with a median of $1.2 million in 2024.
- As far as peak fluctuations go, Axsome Therapeutics' Current Leases tumbled by 8883.43% in 2023, and later skyrocketed by 96759.26% in 2024.
- Axsome Therapeutics' Current Leases (Quarter) stood at $425000.0 in 2022, then surged by 198.12% to $1.3 million in 2023, then surged by 44.83% to $1.8 million in 2024, then soared by 36.08% to $2.5 million in 2025.
- Its Current Leases stands at $2.5 million for Q3 2025, versus $2.0 million for Q2 2025 and $1.8 million for Q1 2025.